| JGIRX | VIGAX | JGIRX / VIGAX | |
| Total Expense Ratio | 0.44 | 0.05 | 880% |
| Annual Report Gross Expense Ratio | 0.50 | 0.05 | 1,000% |
| Fund Existence | 20 years | 26 years | - |
| Gain YTD | 6.374 | 7.072 | 90% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.64B | 394B | 0% |
| Annual Yield % from dividends | 0.18 | 0.36 | 50% |
| Returns for 1 year | 18.21 | 25.13 | 72% |
| Returns for 3 years | 69.28 | 88.89 | 78% |
| Returns for 5 years | 38.98 | 85.17 | 46% |
| Returns for 10 years | 168.11 | 402.82 | 42% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| JAGLX | 82.37 | 1.50 | +1.85% |
| Janus Henderson Global Life Sciences T | |||
| VIGIX | 268.93 | N/A | N/A |
| Vanguard Growth Index Institutional | |||
| IVGAX | 21.24 | N/A | N/A |
| VY® Invesco Growth and Income A | |||
| IBALX | 37.55 | N/A | N/A |
| Transamerica Multi-Managed Balanced A | |||
| AIOCX | 12.17 | N/A | N/A |
| American Century International Opps C | |||